BUY Aurobindo Pharma — Rajesh Satpute, 13 Aug 2026

byRajesh SatputeHorizon: NA (inferred Intraday)13 Aug 2026, 9:25 am ISTvia CNBC Awaaz.

Entry₹1,671.6Inferred

Target₹1,720

Stop loss₹1,660-0.69% risk

Exit₹1,66013 Aug 2026, 1:54 pm

Stop-loss hit-0.69%

Follow Rajesh Satpute for new calls(9% target hit, 94 closed calls)Get alerts Watch AUROPHARMA for new buy/sell callsGet alerts See 1 active Intraday call on AUROPHARMA See 17 active Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Aug 2026

6 supporting0 opposing

Supports the BUY call (6)

Aurobindo Pharma Expands Margins as Sales Grow

NewsGoogle News·12 Aug · today

4 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·12 Aug · yesterday

Results: Aurobindo Pharma Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

NewsGoogle News·8 Aug · 5d ago

Aurobindo Pharma rises 3% after Q1 beat; HDFC Securities retains 'Add', Axis Securities cuts to 'Hold'

NewsGoogle News·7 Aug · 6d ago

Hold Aurobindo Pharma; target of Rs 1600: Prabhudas Lilladher

NewsGoogle News·7 Aug · 6d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.